Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as monitors, ventilators, defibrillators systems, anesthesia machines, operating tables, surgical lights, suspension towers, infusion pumps, electrocardiographs, operating room and intensive care unit solutions, ultrasound, radiology, AED, CLIA, medical supply units, orthopedics, obstretrics, gynecology,, cardiovascular intervention, animal medical, and artema GAS module and accessories, as well as emergency care, perioperative care, critical care, and IT solutions. It also provides a series of instruments and solutions for life information monitoring and support, as well as a series of minimally invasive surgical products, including surgical laparoscopic camera systems, cold light sources, pneumoperitoneum machines, optical endoscopes, ultrasonic scalpels, energy platforms, minimally invasive surgical instruments and consumables. In addition, the company offers in-vitro diagnostics products, including hematology analyzers and reagents, micro plate readers and washers coagulation, and microbiology solutions; medical imaging systems comprising ultrasound and radiology products; and veterinary products, as well as chemiluminescence immunoassay analyzers, blood cell analyzers, biochemical analyzers, coagulation analyzers, urine analyzers, microbial diagnostic systems, glycated hemoglobin analyzers, and related reagents, which obtain clinical diagnostic information through testing of human samples, such as blood, body fluids, tissues, etc. The company was founded in 1991 and is headquartered in Shenzhen, the People’s Republic of China.
Metrics to compare | 300760 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300760PeersSector | |
---|---|---|---|---|
P/E Ratio | 25.3x | 28.2x | −0.5x | |
PEG Ratio | −3.00 | 0.11 | 0.00 | |
Price/Book | 7.3x | 2.3x | 2.6x | |
Price / LTM Sales | 7.9x | 4.3x | 3.2x | |
Upside (Analyst Target) | 28.7% | 26.4% | 41.6% | |
Fair Value Upside | Unlock | 23.3% | 6.0% | Unlock |